Alyeska Investment Group, L.P. Point Biopharma Global Inc. Transaction History

Alyeska Investment Group, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.24 - $10.31 $3.37 Million - $4.8 Million	-465,207 Reduced 57.34%	346,171 $2.68 Million
Q2 2022 Aug 15, 2022	SELL	$5.6 - $9.5 $204,618 - $347,120	-36,539 Reduced 4.31%	811,378 $5.53 Million
Q4 2021 Feb 14, 2022	BUY	$4.83 - $9.75 $129,902 - $262,226	26,895 Added 3.28%	847,917 $4.75 Million
Q3 2021 Nov 15, 2021	BUY	$7.42 - $11.26 $6.09 Million - $9.24 Million	821,022 New	821,022 $6.31 Million

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.